These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 20148658

  • 1. Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
    Lai TY, Lam CP, Luk FO, Chan RP, Chan WM, Liu DT, Lam DS.
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):91-5. PubMed ID: 20148658
    [Abstract] [Full Text] [Related]

  • 2. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
    Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
    [Abstract] [Full Text] [Related]

  • 3. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [Abstract] [Full Text] [Related]

  • 4. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS.
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [Abstract] [Full Text] [Related]

  • 5. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy.
    Kim SJ, Yu HG.
    Retina; 2011 Oct; 31(9):1827-34. PubMed ID: 21734621
    [Abstract] [Full Text] [Related]

  • 7. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sato T, Kishi S, Matsumoto H, Mukai R.
    Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
    [Abstract] [Full Text] [Related]

  • 8. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
    Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS.
    Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [Abstract] [Full Text] [Related]

  • 10. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.
    Tomita K, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Otani A, Nakayama Y, Yoshimura N.
    Am J Ophthalmol; 2012 Jan; 153(1):68-80.e1. PubMed ID: 21907965
    [Abstract] [Full Text] [Related]

  • 11. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
    Lai TY, Lee GK, Luk FO, Lam DS.
    Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
    [Abstract] [Full Text] [Related]

  • 13. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A, Shiraga F, Shiragami C, Shirakata Y, Fujiwara A.
    Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Jain P, Anantharaman G, Gopalakrishnan M, Goyal A.
    Indian J Ophthalmol; 2018 Aug; 66(8):1119-1127. PubMed ID: 30038155
    [Abstract] [Full Text] [Related]

  • 15. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A, Shiraga F, Shiragami C, Ono A, Tenkumo K.
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [Abstract] [Full Text] [Related]

  • 17. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T.
    Am J Ophthalmol; 2011 Apr; 151(4):594-603.e1. PubMed ID: 21295766
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up.
    Lee YA, Yang CH, Yang CM, Ho TC, Lin CP, Huang JS, Chen MS.
    Am J Ophthalmol; 2012 Nov; 154(5):872-880.e2. PubMed ID: 22831838
    [Abstract] [Full Text] [Related]

  • 19. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kang HM, Kim YM, Koh HJ.
    Am J Ophthalmol; 2013 Mar; 155(3):438-447.e1. PubMed ID: 23218705
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.